ProSalud Program for Cancer Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the interest of Latino families in rural Florida in the ProSalud program, which teaches cancer prevention. The goal is to determine if the program, covering topics like healthy eating, staying active, and sun protection, helps families make healthier choices to reduce cancer risk. Participants will share their opinions to improve the program for the future. Latino parents with children aged 6 to 12 who speak Spanish and have basic reading and writing skills are well-suited for this trial.
As an unphased study, this trial offers families a unique opportunity to contribute to the development of a culturally tailored cancer prevention program.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational workshops, so it's unlikely that medication changes are required.
What prior data suggests that the ProSalud program is safe for Latino families?
Research has shown that the ProSalud program helps prevent cancer by promoting healthy habits. It involves no medical treatments or drugs. Instead, it focuses on teaching Latino families about lifestyle changes, such as eating well and staying active. As an educational program rather than a drug trial, it poses no concerns about physical safety or side effects. Participants will engage in workshops and discussions, designed to be safe and informative.12345
Why are researchers excited about this trial?
Researchers are excited about the ProSalud Program because it takes a culturally tailored approach to cancer prevention, specifically designed for the Latino community. Unlike standard cancer prevention methods that may not consider cultural nuances, ProSalud aims to boost engagement by addressing the unique needs and preferences of this group. The program not only focuses on reducing cancer risk behaviors through education but also actively involves participants in refining the intervention, ensuring it is both feasible and acceptable. This participatory approach could lead to more effective and sustainable cancer prevention strategies within the community.
What evidence suggests that the ProSalud program is effective for cancer prevention?
Research has shown that programs like ProSalud, studied in this trial, can significantly aid in cancer prevention. Studies have found that similar programs can reduce cancer risk by up to 58.5% by promoting healthy habits such as regular check-ups and lifestyle changes. Other community health programs have also reported significant increases in cancer prevention actions among participants. These programs provide people with the knowledge to make healthier choices, an important step in reducing cancer risk. Overall, evidence suggests that ProSalud could effectively help Latino families adopt healthier habits to lower their cancer risk.46789
Who Is on the Research Team?
Peter Kanetsky, MPH, PhD
Principal Investigator
Moffitt Cancer Center
Marilyn Stern, PhD
Principal Investigator
University of South Florida
Are You a Good Fit for This Trial?
This trial is for Latino parents living in rural Florida with children aged 6-12. It aims to educate them on cancer prevention through healthy habits. Participants will attend a workshop and may be selected for a focus group to provide feedback.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Workshop
Latino parents with children between the ages of 6 and 12 participate in a one-hour (or one-and-a-half-hour) workshop on healthy habits
Focus Group
Some parents who participated in the workshops are randomly chosen to join a focus group to provide feedback on the program
Follow-up
Participants are monitored for feedback and effectiveness of the program
What Are the Treatments Tested in This Trial?
Interventions
- ProSalud
Find a Clinic Near You
Who Is Running the Clinical Trial?
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor